Experimental and computational models to investigate intestinal drug permeability and metabolism

References

• Abouir K, Samer CF, Gloor Y, Desmeules JA, Daali Y. 2021. Reviewing data integrated for PBPK model development to predict metabolic drug-drug interactions: shifting perspectives and emerging trends. Front Pharmacol. 12:708299.
   PubMed Web of Science ®Google Scholar
• Agoram B, Woltosz WS, Bolger MB. 2001. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev. 50(Suppl 1):S41–S67.
   PubMed Web of Science ®Google Scholar
• Ahire DS, Basit A, Karasu M, Prasad B. 2021. Ultrasensitive quantification of drug-metabolizing enzymes and transporters in small sample volume by microflow LC-MS/MS. J Pharm Sci. 110(7):2833–2840.
   PubMed Web of Science ®Google Scholar
• Ali AMA, Zawbaa HM, Sayed OM, Harb HS, Saeed H, Boshra MS, Almeldien AG, Salah Eldin R, Elberry AA, Abdelwahab NS. et al.. 2021. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: a complementary study of neural networks, genetic algorithms and decision trees. Int J Clin Pract. 75:e13764.
   PubMed Web of Science ®Google Scholar
• Alqahtani S. 2017. In silico ADME-Tox modeling: progress and prospects. Expert Opin Drug Metab Toxicol. 13(11):1147–1158.
   PubMed Web of Science ®Google Scholar
• Alqahtani S, Mohamed LA, Kaddoumi A. 2013. Experimental models for predicting drug absorption and metabolism. Expert Opin Drug Metab Toxicol. 9:1241–1254.
   PubMed Web of Science ®Google Scholar
• Arnold M, Méndez-Carmona N, Wyss RK, Joachimbauer A, Casoni D, Carrel T, Longnus S. 2020. Comparison of experimental rat models in donation after circulatory death (dcd): in-situ vs. ex-situ ischemia. Front Cardiovasc Med. 7:596883.
   PubMed Web of Science ®Google Scholar
• Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175(3):880–885.
   PubMed Web of Science ®Google Scholar
• Artursson P, Ungell AL, Löfroth JE. 1993. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm Res. 10(8):1123–1129.
   PubMed Web of Science ®Google Scholar
• Avdeef A. 2005. The rise of PAMPA. Expert Opin Drug Metab Toxicol. 1(2):325–342.
   PubMedGoogle Scholar
• Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, Korennykh A, Donia MS. 2021. The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature. 600:110–115.
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S, Morrison RA. 2000. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods. 44(1):301–312.
   PubMed Web of Science ®Google Scholar
• Barnett AM, Roy NC, Cookson AL, McNabb WC. 2018. Metabolism of caprine milk carbohydrates by probiotic bacteria and caco-2: HT29-mtx epithelial co-cultures and their impact on intestinal barrier integrity. Nutrients. 10(7):949.
   Web of Science ®Google Scholar
• Bauer E, Thiele I. 2018. From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota. mSystems, 3.
   Google Scholar
• Béduneau A, Tempesta C, Fimbel S, Pellequer Y, Jannin V, Demarne F, Lamprecht A. 2014. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur J Pharm Biopharm. 87(2):290–298.
   PubMed Web of Science ®Google Scholar
• Beeck R, Glöckl G, Krause J, Schick P, Weitschies W. 2021. Mimicking the dynamic Colonic microbiota in vitro to gain a better understanding on the in vivo metabolism of xenobiotics: degradation of sulfasalazine. Int J Pharm. 603:120704.
   PubMed Web of Science ®Google Scholar
• Behrens I, Stenberg P, Artursson P, Kissel T. 2001. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res. 18:1138–1145.
   PubMed Web of Science ®Google Scholar
• Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. 2018. Microfluidic organ-on-a-chip models of human intestine. Cell Mol Gastroenterol Hepatol. 5(4):659–668.
   PubMed Web of Science ®Google Scholar
• Bhat MP, Kurkuri M, Losic D, Kigga M, Altalhi T. 2021. New optofluidic based lab-on-a-chip device for the real-time fluoride analysis. Anal Chim Acta. 1159:338439.
   PubMed Web of Science ®Google Scholar
• Bhatia SN, Ingber DE. 2014. Microfluidic organs-on-chips. Nat Biotechnol. 32(8):760–772.
   PubMed Web of Science ®Google Scholar
• Boerner K, Luissint AC, Parkos CA. 2021. Functional assessment of intestinal permeability and neutrophil transepithelial migration in mice using a standardized intestinal loop model. J Vis Exp. 168.
   PubMed Web of Science ®Google Scholar
• Bois FY. 2010. Physiologically based modelling and prediction of drug interactions. Basic Clin Pharmacol Toxicol. 106(3):154–161.
   PubMed Web of Science ®Google Scholar
• Borbás E, Balogh A, Bocz K, Müller J, Kiserdei É, Vigh T, Sinkó B, Marosi A, Halász A, Dohányos Z, et al. 2015. In vitro dissolution-permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using μFlux™. Int J Pharm. 491(1-2):180–189.
   PubMed Web of Science ®Google Scholar
• Borbás E, Tőzsér P, Tsinman K, Tsinman O, Takács-Novák K, Völgyi G, Sinkó B, Nagy ZK. 2018. Effect of formulation additives on drug transport through size-exclusion membranes. Mol Pharm. 15(8):3308–3317.
   PubMed Web of Science ®Google Scholar
• Bourdet DL, Pollack GM, Thakker DR. 2006. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells. Pharm Res. 23(6):1178–1187.
   PubMed Web of Science ®Google Scholar
• Bouzom F, Walther B. 2008. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling. Fundam Clin Pharmacol. 22(6):579–587.
   PubMed Web of Science ®Google Scholar
• Brück S, Strohmeier J, Busch D, Drozdzik M, Oswald S. 2017. Caco-2 cells – expression, regulation and function of drug transporters compared with human jejunal tissue. Biopharm Drug Dispos. 38(2):115–126.
   PubMed Web of Science ®Google Scholar
• Brun P, Gobbo S, Caputi V, Spagnol L, Schirato G, Pasqualin M, Levorato E, Palù G, Giron MC, Castagliuolo I. 2015. Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells. Mol Cell Neurosci. 68:24–35.
   PubMed Web of Science ®Google Scholar
• Buckley ST, Fischer SM, Fricker G, Brandl M. 2012. In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives. Eur J Pharm Sci. 45(3):235–250.
   PubMed Web of Science ®Google Scholar
• Caldwell GW, Easlick SM, Gunnet J, Masucci JA, Demarest K. 1998. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom. 33:607–614.
   PubMed Web of Science ®Google Scholar
• Casian T, Borbás E, Ilyés K, Démuth B, Farkas A, Rapi Z, Bogdan C, Iurian S, Toma V, Știufiuc R, et al. 2019. Electrospun amorphous solid dispersions of meloxicam: influence of polymer type and downstream processing to orodispersible dosage forms. Int J Pharm. 569:118593.
   PubMed Web of Science ®Google Scholar
• Chandra L, Borcherding DC, Kingsbury D, Atherly T, Ambrosini YM, Bourgois-Mochel A, Yuan W, Kimber M, Qi Y, Wang Q, et al. 2019. Derivation of adult canine intestinal organoids for translational research in gastroenterology. BMC Biol. 17(1):33.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, Kim DD. 2014. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine. 9:495–504.
   PubMed Web of Science ®Google Scholar
• Choi SM, Kang CY, Lee BJ, Park JB. 2017. In vitro-in vivo correlation using in silico modeling of physiological properties, metabolites, and intestinal metabolism. Curr Drug Metab. 18(11):973–982.
   PubMed Web of Science ®Google Scholar
• Chong S, Dando SA, Soucek KM, Morrison RA. 1996. In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm Res. 13(1):120–123.
   PubMed Web of Science ®Google Scholar
• Cong D, Doherty M, Pang KS. 2000. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism. Drug Metab Dispos. 28(2):224–235.
   PubMed Web of Science ®Google Scholar
• Daniel E, Cleaver O. 2019. Vascularizing organogenesis: lessons from developmental biology and implications for regenerative medicine. Curr Top Dev Biol. 132:177–220.
   PubMed Web of Science ®Google Scholar
• Davies M, Peramuhendige P, King L, Golding M, Kotian A, Penney M, Shah S, Manevski N. 2020. Evaluation of in vitro models for assessment of human intestinal metabolism in drug discovery. Drug Metab Dispos. 48(11):1169–1182.
   PubMed Web of Science ®Google Scholar
• de Kanter R, Monshouwer M, Meijer DK, Groothuis GM. 2002. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr Drug Metab. 3(1):39–59.
   PubMed Web of Science ®Google Scholar
• de Kanter R, Tuin A, van de Kerkhof E, Martignoni M, Draaisma AL, de Jager MH, de Graaf IA, Meijer DK, Groothuis GM. 2005. A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies. J Pharmacol Toxicol Methods. 51(1):65–72.
   PubMedGoogle Scholar
• de Souza J, Benet LZ, Huang Y, Storpirtis S. 2009. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers. J Pharm Sci. 98(11):4413–4419.
   PubMed Web of Science ®Google Scholar
• Dehne EM, Hasenberg T, Marx U. 2017. The ascendance of microphysiological systems to solve the drug testing dilemma. Future Sci Oa. 3(2):Fso185.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. 2003. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem. 38(3):223–232.
   PubMed Web of Science ®Google Scholar
• Dixit P, Jain DK, Dumbwani J. 2012. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods. 65(1):13–17.
   PubMed Web of Science ®Google Scholar
• Dotti I, Mora-Buch R, Ferrer-Picón E, Planell N, Jung P, Masamunt MC, Leal RF, Martín de Carpi J, Llach J, Ordás I, et al. 2017. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut. 66(12):2069–2079.
   PubMed Web of Science ®Google Scholar
• Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science. 308(5728):1635–1638.
   PubMed Web of Science ®Google Scholar
• Englund G, Rorsman F, Rönnblom A, Karlbom U, Lazorova L, Gråsjö J, Kindmark A, Artursson P. 2006. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci. 29(3-4):269–277.
   PubMed Web of Science ®Google Scholar
• Engman HA, Lennernäs H, Taipalensuu J, Otter C, Leidvik B, Artursson P. 2001. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. J Pharm Sci. 90(11):1736–1751.
   PubMed Web of Science ®Google Scholar
• Etienne-Mesmin L, Chassaing B, Desvaux M, De Paepe K, Gresse R, Sauvaitre T, Forano E, de Wiele TV, Schüller S, Juge N, et al. 2019. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol Rev. 43(5):457–489.
   PubMed Web of Science ®Google Scholar
• Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng X-L, Qu L, et al. 2016. Replication of human noroviruses in stem cell-derived human enteroids. Science. 353(6306):1387–1393.
   PubMed Web of Science ®Google Scholar
• Fatehullah A, Tan SH, Barker N. 2016. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 18(3):246–254.
   PubMed Web of Science ®Google Scholar
• Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. 2012. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol. 8(7):e1002606.
   PubMed Web of Science ®Google Scholar
• Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S. 2021. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: a systematic review. J Control Release. 335:247–268.
   PubMed Web of Science ®Google Scholar
• Feist AM, Palsson B. 2008. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotechnol. 26(6):659–667.
   PubMed Web of Science ®Google Scholar
• Feng R, Shou J-W, Zhao Z-X, He C-Y, Ma C, Huang M, Fu J, Tan X-S, Li X-Y, Wen B-Y, et al. 2015. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 5:12155.
   PubMed Web of Science ®Google Scholar
• Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 59(1):221–226.
   PubMed Web of Science ®Google Scholar
• Fossati L, Dechaume R, Hardillier E, Chevillon D, Prevost C, Bolze S, Maubon N. 2008. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs. Int J Pharm. 360(1-2):148–155.
   PubMed Web of Science ®Google Scholar
• Galetin A, Houston JB. 2006. Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism. J Pharmacol Exp Ther. 318(3):1220–1229.
   PubMed Web of Science ®Google Scholar
• Gamboa JM, Leong KW. 2013. In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev. 65:800–810.
   PubMed Web of Science ®Google Scholar
• Gartzke D, Fricker G. 2014. Establishment of optimized MDCK cell lines for reliable efflux transport studies. J Pharm Sci. 103(4):1298–1304.
   PubMed Web of Science ®Google Scholar
• Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, et al. 2010. Membrane transporters in drug development. Nat Rev Drug Discov. 9(3):215–236.
   PubMed Web of Science ®Google Scholar
• Giannakis K, Theocharopoulou G, Papalitsas C, Fanarioti S, Andronikos T. 2020. Particular biomolecular processes as computing paradigms. Adv Exp Med Biol. 1194:225–238.
   PubMed Web of Science ®Google Scholar
• Gjorevski N, Sachs N, Manfrin A, Giger S, Bragina ME, Ordóñez-Morán P, Clevers H, Lutolf MP. 2016. Designer matrices for intestinal stem cell and organoid culture. Nature. 539(7630):560–564.
   PubMed Web of Science ®Google Scholar
• Glaeser H, Fromm MF. 2008. Animal models and intestinal drug transport. Expert Opin Drug Metab Toxicol. 4(4):347–361.
   PubMed Web of Science ®Google Scholar
• Glassman PM, Balthasar JP. 2019. Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development. Drug Metab Pharmacokinet. 34(1):3–13.
   PubMed Web of Science ®Google Scholar
• Göller AH, Kuhnke L, Montanari F, Bonin A, Schneckener S, Ter Laak A, Wichard J, Lobell M, Hillisch A. 2020. Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades. Drug Discov Today. 25(9):1702–1709.
   PubMed Web of Science ®Google Scholar
• Gui W, Shen S, Zhuang Z. 2020. Photocaged cell-permeable ubiquitin probe for temporal profiling of deubiquitinating enzymes. J Am Chem Soc. 142(46):19493–19501.
   PubMed Web of Science ®Google Scholar
• Havenaar R, Anneveld B, Hanff LM, de Wildt SN, de Koning BA, Mooij MG, Lelieveld JP, Minekus M. 2013. In vitro gastrointestinal model (TIM) with predictive power, even for infants and children? Int J Pharm. 457(1):327–332.
   PubMed Web of Science ®Google Scholar
• Herath M, Hosie S, Bornstein JC, Franks AE, Hill-Yardin EL. 2020. The role of the gastrointestinal mucus system in intestinal homeostasis: implications for neurological disorders. Front Cell Infect Microbiol. 10:248.
   PubMed Web of Science ®Google Scholar
• Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 96:736–749.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Burmester M, Langeheine M, Brehm R, Empl MT, Seeger B, Breves G. 2021. Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells. PLoS One. 16(10):e0257824.
   PubMed Web of Science ®Google Scholar
• Holenarsipur VK, Gaud N, Sinha J, Sivaprasad S, Bhutani P, Subramanian M, Singh SP, Arla R, Paruchury S, Sharma T, et al. 2015. Absorption and cleavage of enalapril, a carboxyl ester prodrug, in the rat intestine: in vitro, in situ intestinal perfusion and portal vein cannulation models. Biopharm Drug Dispos. 36(6):385–397.
   PubMed Web of Science ®Google Scholar
• Hosokawa M. 2008. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules. 13(2):412–431.
   PubMed Web of Science ®Google Scholar
• Hu Y, Smith DE. 2019. In silico prediction of the absorption and disposition of cefadroxil in humans using an intestinal permeability method scaled from humanized PepT1 mice. Drug Metab Dispos. 47(3):173–183.
   PubMed Web of Science ®Google Scholar
• Inoue M, Morikawa M, Tsuboi M, Sugiura M. 1979. Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs. Jpn J Pharmacol. 29(1):9–16.
   PubMedGoogle Scholar
• Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR. 1999. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci. 88(1):28–33.
   PubMed Web of Science ®Google Scholar
• Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan A, Tucker G. 2009. Population-based mechanistic prediction of oral drug absorption. Aaps J. 11(2):225–237.
   PubMed Web of Science ®Google Scholar
• Jing J, Nelson C, Paik J, Shirasaka Y, Amory JK, Isoherranen N. 2017. Physiologically based pharmacokinetic model of all-trans-retinoic acid with application to cancer populations and drug interactions. J Pharmacol Exp Ther. 361(2):246–258.
   PubMed Web of Science ®Google Scholar
• Johnson TN, Rostami-Hodjegan A. 2011. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anaesth. 21(3):291–301.
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Zhang QY. 2003. The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos. 31(12):1520–1525.
   PubMed Web of Science ®Google Scholar
• Kammertoens T, Jeuthe S, Baranzke H, Klippert A, Thöne-Reineke C. 2021. Breeding and maintenance of immunodeficient mouse lines under spf conditions-a call for individualized severity analyses and approval procedures. Animals. 11(6):1789.
   Web of Science ®Google Scholar
• Kauffman AL, Gyurdieva AV, Mabus JR, Ferguson C, Yan Z, Hornby PJ. 2013. Alternative functional in vitro models of human intestinal epithelia. Front Pharmacol. 4:79.
   PubMed Web of Science ®Google Scholar
• Kaul S, Ritschel WA. 1981. Studies of the intestinal transfer of coumarin and 7-hydroxycoumarin across guinea pig and rat small intestine. Arzneimittelforschung. 31(5):790–795.
   PubMed Web of Science ®Google Scholar
• Keschenau PR, Simons N, Klingel H, Reuter S, Foldenauer AC, Vieß J, Weidener D, Andruszkow J, Blümich B, Tolba R, et al. 2019. Perfusion-related changes in intestinal diffusion detected by NMR-MOUSE® monitoring in minipigs. Microvasc Res. 125:103876.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE. 2012. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 12(12):2165–2174.
   PubMed Web of Science ®Google Scholar
• Kimura H, Sakai Y, Fujii T. 2018. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 33(1):43–48.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Kahn CR, Accili D. 2003. Insulin receptor knockout mice. Annu Rev Physiol. 65:313–332.
   PubMed Web of Science ®Google Scholar
• Kolars JC, Awni WM, Merion RM, Watkins PB. 1991. First-pass metabolism of cyclosporin by the gut. Lancet. 338(8781):1488–1490.
   PubMed Web of Science ®Google Scholar
• Krüger P, Kanzer J, Hummel J, Fricker G, Schubert-Zsilavecz M, Abdel-Tawab M. 2009. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur J Pharm Sci. 36(2-3):275–284.
   PubMed Web of Science ®Google Scholar
• Kuze J, Mutoh T, Takenaka T, Morisaki K, Nakura H, Hanioka N, Narimatsu S. 2009. Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice. Xenobiotica. 39(11):871–880.
   PubMed Web of Science ®Google Scholar
• Kwon O, Jung KB, Lee KR, Son YS, Lee H, Kim JJ, Kim K, Lee S, Song YK, Jung J. et al. 2021. The development of a functional human small intestinal epithelium model for drug absorption. Sci Adv. 7(23):eabh1586.
   Web of Science ®Google Scholar
• Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ. et al.. 2020. SARS-CoV-2 productively infects human gut enterocytes. Science. 369:50–54.
   PubMed Web of Science ®Google Scholar
• Lancaster MA, Knoblich JA. 2014. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 345(6194):1247125.
   PubMed Web of Science ®Google Scholar
• Lee SH, Choi N, Sung JH. 2019. Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models. Expert Opin Drug Metab Toxicol. 15(12):1005–1019.
   PubMed Web of Science ®Google Scholar
• Li XG, Chen MX, Zhao SQ, Wang XQ. 2022. Intestinal models for personalized medicine: from conventional models to microfluidic primary intestine-on-a-chip. Stem Cell Rev Rep. 18(6):2137–2151.
   PubMed Web of Science ®Google Scholar
• Li M, de Graaf IA, Groothuis GM. 2016. Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research. Expert Opin Drug Metab Toxicol. 12(2):175–190.
   PubMed Web of Science ®Google Scholar
• Li H, Gao L, Du J, Ma T, Ye Z, Li Z. 2021. To better generate organoids, What can we learn from teratomas? Front Cell Dev Biol. 9:700482.
   PubMed Web of Science ®Google Scholar
• Li Y, Shin YG, Yu C, Kosmeder JW, Hirschelman WH, Pezzuto JM, van Breemen RB. 2003. Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb Chem High Throughput Screen. 6(8):757–767.
   PubMed Web of Science ®Google Scholar
• Li H, You J, Wang WX. 2018. Multi-compartmental toxicokinetic modeling of fipronil in tilapia: accumulation, biotransformation and elimination. J Hazard Mater. 360:420–427.
   PubMed Web of Science ®Google Scholar
• Liu L, Liang L, Yang C, Zhou Y, Chen Y. 2021. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes. 13:1–20.
   Web of Science ®Google Scholar
• Liu W, Pan H, Zhang C, Zhao L, Zhao R, Zhu Y, Pan W. 2016. Developments in methods for measuring the intestinal absorption of nanoparticle-bound drugs. Int J Mol Sci. 17(7):1171.
   Web of Science ®Google Scholar
• Liu Y, Zeng S. 2008. [Advances in the MDCK-MDR1 cell model and its applications to screen drug permeability]. Yao Xue Xue Bao. 43(6):559–564.
   PubMedGoogle Scholar
• Lumi X, Dučić T, Kreuzer M, Hawlina M, Andjelic S. 2021. UV effect on human anterior lens capsule macro-molecular composition studied by synchrotron-based FTIR micro-spectroscopy. Int J Mol Sci. 22(10):5249.
   PubMed Web of Science ®Google Scholar
• Luo Z, Liu Y, Zhao B, Tang M, Dong H, Zhang L, Lv B, Wei L. 2013. Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods. 68:208–216.
   PubMed Web of Science ®Google Scholar
• Macfarlane GT, Macfarlane S. 2007. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin Biotechnol. 18(2):156–162.
   PubMed Web of Science ®Google Scholar
• Mahdi WA, Hussain A, Altamimi MA, Alshehri S, Bukhari SI, Ahsan MN. 2021. Experimental solubility, thermodynamic/computational validations, and gastroplus-based in silico prediction for subcutaneous delivery of rifampicin. AAPS PharmSciTech. 22(3):116.
   PubMed Web of Science ®Google Scholar
• Maher S, Devocelle M, Ryan S, McClean S, Brayden DJ. 2010. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin. Int J Pharm. 387(1-2):154–160.
   PubMed Web of Science ®Google Scholar
• Majzoub JA, Muglia LJ. 1996. Knockout mice. N Engl J Med. 334(14):904–907.
   PubMed Web of Science ®Google Scholar
• Marsousi N, Desmeules JA, Rudaz S, Daali Y. 2018. Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software. Biopharm Drug Dispos. 39:3–17.
   PubMed Web of Science ®Google Scholar
• Marteau P, Minekus M, Havenaar R, Huis in’t Veld JH. 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci. 80:1031–1037.
   PubMed Web of Science ®Google Scholar
• Martín R, Bermúdez-Humarán LG, Langella P. 2016. Gnotobiotic rodents: an in vivo model for the study of microbe-microbe interactions. Front Microbiol. 7:409.
   PubMed Web of Science ®Google Scholar
• Martišienė I, Mačianskienė R, Benetis R, Jurevičius J. 2020. Cardiac optical mapping in situ in swine models: a view of the current situation. Medicina (Kaunas). 56(11):620.
   Web of Science ®Google Scholar
• Maubon N, Le Vee M, Fossati L, Audry M, Le Ferrec E, Bolze S, Fardel O. 2007. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam Clin Pharmacol. 21(6):659–663.
   PubMed Web of Science ®Google Scholar
• McClean S, Prosser E, Meehan E, O'Malley D, Clarke N, Ramtoola Z, Brayden D. 1998. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci. 6(2):153–163.
   PubMed Web of Science ®Google Scholar
• McConnell RE, Higginbotham JN, Shifrin DA, Jr., Tabb DL, Coffey RJ, Tyska MJ. 2009. The enterocyte microvillus is a vesicle-generating organelle. J Cell Biol. 185(7):1285–1298.
   PubMed Web of Science ®Google Scholar
• Mochel JP, Jergens AE, Kingsbury D, Kim HJ, Martín MG, Allenspach K. 2017. Intestinal stem cells to advance drug development, precision, and regenerative medicine: a paradigm shift in translational research. Aaps J. 20(1):17.
   PubMed Web of Science ®Google Scholar
• Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA. 2012. Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today. 17(1-2):44–55.
   PubMed Web of Science ®Google Scholar
• Mudra DR, Jin JY, Borchardt RT. 2010. Absorption barriers in the rat intestinal mucosa: 2. Application of physiologically based mathematical models to quantify mechanisms of drug permeation and metabolism. J Pharm Sci. 99(2):999–1015.
   PubMed Web of Science ®Google Scholar
• Murakami T, Nakanishi M, Yoshimori T, Okamura N, Norikura R, Mizojiri K. 2003. Separate assessment of intestinal and hepatic first-pass effects using a rat model with double cannulation of the portal and jugular veins. Drug Metab Pharmacokinet. 18(4):252–260.
   PubMedGoogle Scholar
• Nakamura T, Sakaeda T, Ohmoto N, Tamura T, Aoyama N, Shirakawa T, Kamigaki T, Nakamura T, Kim KI, Kim SR. et al.. 2002. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab Dispos. 30:4–6.
   PubMed Web of Science ®Google Scholar
• Negoro R, Takayama K, Nagamoto Y, Sakurai F, Tachibana M, Mizuguchi H. 2016. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells. Biochem Biophys Res Commun. 472(4):631–636.
   PubMed Web of Science ®Google Scholar
• Olivo Pimentel V, Yaromina A, Marcus D, Dubois LJ, Lambin P. 2020. A novel co-culture assay to assess anti-tumor CD8(+) T cell cytotoxicity via luminescence and multicolor flow cytometry. J Immunol Methods. 487:112899.
   PubMed Web of Science ®Google Scholar
• Otto AM. 2016. Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 4:5.
   PubMedGoogle Scholar
• Pappo J, Ermak TH. 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer’s patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol. 76(1):144–148.
   PubMed Web of Science ®Google Scholar
• Parrott N, Lave T. 2008. Applications of physiologically based absorption models in drug discovery and development. Mol Pharm. 5(5):760–775.
   PubMed Web of Science ®Google Scholar
• Paul P, Jones FA. 2016. Advanced wastewater treatment engineering-investigating membrane fouling in both rotational and static membrane bioreactor systems using empirical modelling. Int J Environ Res Public Health. 13(1):100.
   Web of Science ®Google Scholar
• Peng Y, Yadava P, Heikkinen AT, Parrott N, Railkar A. 2014. Applications of a 7-day Caco-2 cell model in drug discovery and development. Eur J Pharm Sci. 56:120–130.
   PubMed Web of Science ®Google Scholar
• Pereira C, Araújo F, Barrias CC, Granja PL, Sarmento B. 2015. Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies. Biomaterials. 56:36–45.
   PubMed Web of Science ®Google Scholar
• Pham VT, Mohajeri MH. 2018. The application of in vitro human intestinal models on the screening and development of pre- and probiotics. Benef Microbes. 9(5):725–742.
   PubMed Web of Science ®Google Scholar
• Pham BT, van Haaften WT, Oosterhuis D, Nieken J, de Graaf IA, Olinga P. 2015. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiol Rep. 3(4):e12323.
   PubMedGoogle Scholar
• Polli JE. 2008. In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms. Aaps j. 10:289–299.
   PubMed Web of Science ®Google Scholar
• Press B, Di Grandi D. 2008. Permeability for intestinal absorption: caco-2 assay and related issues. Curr Drug Metab. 9(9):893–900.
   PubMed Web of Science ®Google Scholar
• Puschhof J, Pleguezuelos-Manzano C, Clevers H. 2021. Organoids and organs-on-chips: insights into human gut-microbe interactions. Cell Host Microbe. 29(6):867–878.
   PubMed Web of Science ®Google Scholar
• Rong Z, Huang Y, Cai H, Chen M, Wang H, Liu G, Zhang Z, Wu J. 2021. Gut microbiota disorders promote inflammation and aggravate spinal cord injury through the TLR4/MyD88 signaling pathway. Front Nutr. 8:702659.
   PubMed Web of Science ®Google Scholar
• Saha C, Horst-Kreft D, Kross I, van der Spek PJ, Louwen R, van Baarlen P. 2020. Campylobacter jejuni Cas9 modulates the transcriptome in Caco-2 intestinal epithelial cells. Genes (Basel). 11(10):1193.
   PubMed Web of Science ®Google Scholar
• Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 459(7244):262–265.
   PubMed Web of Science ®Google Scholar
• Satoh T, Narazaki G, Sugita R, Kobayashi H, Sugiura S, Kanamori T. 2016. A pneumatic pressure-driven multi-throughput microfluidic circulation culture system. Lab Chip. 16(12):2339–2348.
   PubMed Web of Science ®Google Scholar
• Schimpel C, Teubl B, Absenger M, Meindl C, Fröhlich E, Leitinger G, Zimmer A, Roblegg E. 2014. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm. 11(3):808–818.
   PubMed Web of Science ®Google Scholar
• Schinkel AH, Mol CA, Wagenaar E, van Deemter L, Smit JJ, Borst P. 1995. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur J Cancer. 31a(7-8):1295–1298.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14(8):e1002533.
   PubMed Web of Science ®Google Scholar
• Serra D, Mayr U, Boni A, Lukonin I, Rempfler M, Challet Meylan L, Stadler MB, Strnad P, Papasaikas P, Vischi D. et al.. 2019. Self-organization and symmetry breaking in intestinal organoid development. Nature. 569:66–72.
   PubMed Web of Science ®Google Scholar
• Sevin E, Dehouck L, Fabulas-da Costa A, Cecchelli R, Dehouck MP, Lundquist S, Culot M. 2013. Accelerated Caco-2 cell permeability model for drug discovery. J Pharmacol Toxicol Methods. 68(3):334–339.
   PubMed Web of Science ®Google Scholar
• Sevin E, Dehouck L, Versele R, Culot M, Gosselet F. 2019. A miniaturized pump out method for characterizing molecule interaction with ABC transporters. Int J Mol Sci. 20(22):5529.
   PubMed Web of Science ®Google Scholar
• Shahbazi MA, Santos HA. 2013. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab. 14(1):28–56.
   PubMed Web of Science ®Google Scholar
• Sharma P, Chawla HP, Panchagnula R. 2002. LC determination of cephalosporins in in vitro rat intestinal sac absorption model. J Pharm Biomed Anal. 27:39–50.
   PubMed Web of Science ®Google Scholar
• Shen JY, Yang XL, Yang ZL, Kou JP, Li F. 2015. Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil. Drug Des Devel Ther. 9:4685–4693.
   PubMed Web of Science ®Google Scholar
• Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. 2018. Application of in silico tools in clinical practice using ketoconazole as a model drug. J Pharm Pharm Sci. 21:242s–53s.
   PubMed Web of Science ®Google Scholar
• Smit B, Chinaka CC, Scott AA, Gaiduschek K, Hatje E, Kuballa A, Coulson S, Finlayson W, Katouli M. 2022. Efficacy of selected live biotherapeutic candidates to inhibit the interaction of an adhesive-invasive escherichia coli strain with Caco-2, HT29-MTX Cells and their co-culture. Biomedicines. 10(9):2245.
   PubMed Web of Science ®Google Scholar
• Smith MC, Gheux A, Coton M, Madec S, Hymery N, Coton E. 2018. In vitro co-culture models to evaluate acute cytotoxicity of individual and combined mycotoxin exposures on Caco-2, THP-1 and HepaRG human cell lines. Chem Biol Interact. 281:51–59.
   PubMed Web of Science ®Google Scholar
• Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn AM, et al. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 470(7332):105–9.
   PubMed Web of Science ®Google Scholar
• Spencer NJ, Hu H. 2020. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 17(6):338–351.
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Brouwers J, Annaert P, Augustijns P. 2015. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 478(2):665–81.
   PubMed Web of Science ®Google Scholar
• Stevenson CL, Augustijns PF, Hendren RW. 1999. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. Int J Pharm. 177(1):103–15.
   PubMed Web of Science ®Google Scholar
• Stock V, Böhmert L, Lisicki E, Block R, Cara-Carmona J, Pack LK, Selb R, Lichtenstein D, Voss L, Henderson CJ. et al. 2019. Uptake and effects of orally ingested polystyrene microplastic particles in vitro and in vivo. Arch Toxicol. 93:1817–33.
   PubMed Web of Science ®Google Scholar
• Stoll F, Göller AH, Hillisch A. 2011. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds. Drug Discov Today. 16(11-12):530–8.
   PubMed Web of Science ®Google Scholar
• Sugano K, Hamada H, Machida M, Ushio H, Saitoh K, Terada K. 2001. Optimized conditions of bio-mimetic artificial membrane permeation assay. Int J Pharm. 228(1-2):181–8.
   PubMed Web of Science ®Google Scholar
• Šuligoj T, Vigsnæs LK, Abbeele PVD, Apostolou A, Karalis K, Savva GM, McConnell B, Juge N. 2020. Effects of human milk oligosaccharides on the adult gut microbiota and barrier function. Nutrients. 12(9):2808.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Murano T, Shimizu H, Ito G, Nakata T, Fujii S, Ishibashi F, Kawamoto A, Anzai S, Kuno R. et al. 2018. Single cell analysis of Crohn’s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties. J Gastroenterol. 53:1035–47.
   PubMed Web of Science ®Google Scholar
• Takebe T, Enomura M, Yoshizawa E, Kimura M, Koike H, Ueno Y, Matsuzaki T, Yamazaki T, Toyohara T, Osafune K. et al. 2015. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell. 16:556–65.
   PubMed Web of Science ®Google Scholar
• Takemoto K, Yamazaki H, Tanaka Y, Nakajima M, Yokoi T. 2003. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica. 33(1):43–55.
   PubMed Web of Science ®Google Scholar
• Takesue Y, Mikamo H, Kusachi S, Watanabe S, Takahashi K, Yoshinari T, Ishii M, Aikawa N. 2015. Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study. Diagn Microbiol Infect Dis. 83(1):77–81.
   PubMed Web of Science ®Google Scholar
• Tam D, Tirona RG, Pang KS. 2003. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption. Drug Metab Dispos. 31(4):373–83.
   PubMed Web of Science ®Google Scholar
• Tammela P, Laitinen L, Galkin A, Wennberg T, Heczko R, Vuorela H, Slotte JP, Vuorela P. 2004. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch Biochem Biophys. 425(2):193–9.
   PubMed Web of Science ®Google Scholar
• Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S. 2015. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: in vitro, ex vivo, and in vivo investigations. Colloids Surf B Biointerfaces. 128:448–456.
   PubMed Web of Science ®Google Scholar
• Thelen K, Coboeken K, Willmann S, Burghaus R, Dressman JB, Lippert J. 2011. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions. J Pharm Sci. 100(12):5324–45.
   PubMed Web of Science ®Google Scholar
• Tong S, Zhang P, Cheng Q, Chen M, Chen X, Wang Z, Lu X, Wu H. 2022. The role of gut microbiota in gout: is gut microbiota a potential target for gout treatment. Front Cell Infect Microbiol. 12:1051682.
   PubMed Web of Science ®Google Scholar
• Tsunoda SM, Velez RL, von Moltke LL, Greenblatt DJ. 1999. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Clin Pharmacol Ther. 66:461–71.
   PubMed Web of Science ®Google Scholar
• Uriot O, Chalancon S, Mazal C, Etienne-Mesmin L, Denis S, Blanquet-Diot S. 2021. Use of the dynamic tim-1 model for an in-depth understanding of the survival and virulence gene expression of shiga toxin-producing escherichia coli in the human stomach and small intestine. Methods Mol Biol. 2291:297–315.
   PubMedGoogle Scholar
• Usansky HH, Hu P, Sinko PJ. 2008. Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats. Drug Metab Dispos. 36(5):863–9.
   PubMed Web of Science ®Google Scholar
• Vaessen SF, van Lipzig MM, Pieters RH, Krul CA, Wortelboer HM, van de Steeg E. 2017. Regional expression levels of drug transporters and metabolizing enzymes along the pig and human intestinal tract and comparison with Caco-2 cells. Drug Metab Dispos. 45(4):353–360.
   PubMed Web of Science ®Google Scholar
• van Breemen RB, Li Y. 2005. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol. 1(2):175–85.
   PubMedGoogle Scholar
• van de Kerkhof EG, de Graaf IA, Groothuis GM. 2007. In vitro methods to study intestinal drug metabolism. Curr Drug Metab. 8(7):658–75.
   PubMed Web of Science ®Google Scholar
• Vargas M, Franklin MR. 1997. Intestinal UDP-glucuronosyltransferase activities in rat and rabbit. Xenobiotica. 27(5):413–21.
   PubMed Web of Science ®Google Scholar
• Vassilev I, Averesch NJH, Ledezma P, Kokko M. 2021. Anodic electro-fermentation: empowering anaerobic production processes via anodic respiration. Biotechnol Adv. 48:107728.
   PubMed Web of Science ®Google Scholar
• Venema K, van den Abbeele P. 2013. Experimental models of the gut microbiome. Best Pract Res Clin Gastroenterol. 27(1):115–26.
   PubMed Web of Science ®Google Scholar
• Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. 2015. The impact of food bioactives on health: in vitro and ex vivo models. Cham (CH): Springer.
   Google Scholar
• Verwei M, Freidig AP, Havenaar R, Groten JP. 2006. Predicted serum folate concentrations based on in vitro studies and kinetic modeling are consistent with measured folate concentrations in humans. J Nutr. 136(12):3074–8.
   PubMed Web of Science ®Google Scholar
• Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R. et al. 2018. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 359:920–6.
   PubMed Web of Science ®Google Scholar
• Wang X, Dong Y, Song R, Yu A, Wei J, Fan Q, Yao J, Shan D, Zhong X, Lv F, et al. 2022. Intestinal metabolism and absorption mechanism of multi-components in Gaultheria leucocarpa var. yunnanensis – an assessment using in situ and in vitro models, comparing gut segments in pathological with physiological conditions. J Ethnopharmacol. 286:114844.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hop CE, Leung KH, Pang J. 2000. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 35:71–6.
   PubMed Web of Science ®Google Scholar
• Wang L, Rustum AM. 2022. Determination of firocoxib and its related substances in bulk drug substance batches of firocoxib by a high-speed reversed-phase HPLC method with a short fused-core biphenyl column. J Chromatogr Sci. bmac095.
   Web of Science ®Google Scholar
• Wang L, Wu J, Chen J, Dou W, Zhao Q, Han J, Liu J, Su W, Li A, Liu P. et al. 2021. Advances in reconstructing intestinal functionalities in vitro: from two/three dimensional-cell culture platforms to human intestine-on-a-chip. Talanta. 226:122097.
   PubMed Web of Science ®Google Scholar
• Westerhout J, van de Steeg E, Grossouw D, Zeijdner EE, Krul CA, Verwei M, Wortelboer HM. 2014. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci. 63:167–77.
   PubMed Web of Science ®Google Scholar
• Wilson TH, Wiseman G. 1954. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J Physiol. 123:116–25.
   PubMed Web of Science ®Google Scholar
• Wohnsland F, Faller B. 2001. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J Med Chem. 44(6):923–30.
   PubMed Web of Science ®Google Scholar
• Wu KC, Lin CJ. 2019. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: evidences in inflammatory diseases and age-related disorders. J Food Drug Anal. 27(1):48–59.
   PubMed Web of Science ®Google Scholar
• Yang QJ, Bukuroshi P, Quach HP, Chow ECY, Pang KS. 2018. Highlighting vitamin D receptor-targeted activities of 1α,25-dihydroxyvitamin d(3) in mice via physiologically based pharmacokinetic-pharmacodynamic modeling. Drug Metab Dispos. 46(1):75–87.
   PubMed Web of Science ®Google Scholar
• Yang QJ, Fan J, Chen S, Liu L, Sun H, Pang KS. 2016. Metabolite kinetics: the segregated flow model for intestinal and whole body physiologically based pharmacokinetic modeling to describe intestinal and hepatic glucuronidation of morphine in rats in vivo. Drug Metab Dispos. 44:1123–38.
   PubMed Web of Science ®Google Scholar
• Yin YB, de Jonge HR, Wu X, Yin YL. 2019. Mini-gut: a promising model for drug development. Drug Discov Today. 24:1784–94.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL. 1999. A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm. 186(2):119–25.
   PubMed Web of Science ®Google Scholar
• Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ. 2013. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm. 10:1865–73.
   PubMed Web of Science ®Google Scholar
• Yun YE, Edginton AN. 2019. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds. J Toxicol Environ Health A. 82(14):789–814.
   PubMed Web of Science ®Google Scholar
• Zhang H, Bu F, Li L, Jiao Z, Ma G, Cai W, Zhuang X, Lin HS, Shin JG, Xiang X. 2018. Prediction of drug-drug interaction between tacrolimus and principal ingredients of Wuzhi capsule in Chinese healthy volunteers using physiologically-based pharmacokinetic modelling. Basic Clin Pharmacol Toxicol. 122(3):331–340.
   PubMed Web of Science ®Google Scholar
• Zhang M, Pan Y, Dong Q, Tang X, Xin Y, Yin B, Zhu J, Kou X, Ho CT, Huang Q. 2021. Development of organogel-based emulsions to enhance the loading and bioaccessibility of 5-demethylnobiletin. Food Res Int. 148:110592.
   PubMed Web of Science ®Google Scholar
• Zhao R, Coker OO, Wu J, Zhou Y, Zhao L, Nakatsu G, Bian X, Wei H, Chan AWH, Sung JJY. et al. 2020. Aspirin reduces colorectal tumor development in mice and gut microbes reduce its bioavailability and chemopreventive effects. Gastroenterology. 159:969–83.e4.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zeng Z, Sun J, Zhang Y, Li D, Zhang X, Liu M, Wang X. 2017. A novel model of p-glycoprotein inhibitor screening using human small intestinal organoids. Basic Clin Pharmacol Toxicol. 120:250–5.
   PubMed Web of Science ®Google Scholar
• Zheng X, Cai X, Hao H. 2022. Emerging targetome and signalome landscape of gut microbial metabolites. Cell Metab. 34(1):35–58.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Lu C. 2016. PBPK modeling and simulation in drug research and development. Acta Pharm Sin B. 6(5):430–440.
   PubMed Web of Science ®Google Scholar
• Zietek T, Boomgaarden WAD, Rath E. 2021. Drug screening, oral bioavailability and regulatory aspects: a need for human organoids. Pharmaceutics. 13(8):1280.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. 2019a. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 570:462–7.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. 2019b. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science. 363(6247):eaat9931.
   Google Scholar